UNSPSC 51311705: Phenyltoloxamine dihydrogen citrate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H21NO.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8UE48MJH8M, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-toloxy)ethylamine dihydrogen citrate but more generally known as phenyltoloxamine citrate, which bears US NIH Compound Identifier 14440. European Medicines Agency schedules Phenyltoloxamine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03784MIG.

Most nations, for tariff and trade purposes, schedule phenyltoloxamine dihydrogen citrate under HS 29221980. SMILES: CN(C)CCOC1CCCCC1CC2CCCCC2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

UNSPSC 51311705 Phenyltoloxamine dihydrogen citrate is a Commodity code that in recent state and local practice does not map cleanly to the actual work being procured. The code nominally names a specific pharmaceutical ingredient, but the three recent opportunities in the dataset involve procurement of finished naloxone products, generic multi-source pharmaceuticals and OTC items through cooperative purchasing, and pharmacy benefit program direct-to-manufacturer contracting — none of which centers on phenyltoloxamine dihydrogen citrate as a raw material or finished good. The mismatch suggests either a coding error in the state and local systems tagging these opportunities or that the code's use in practice has diverged substantially from its formal definition. State and local buyers in this space are issuing solicitations through county health departments (Seminole County, Florida), state HHS commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon), with the cooperative purchasing vehicle appearing as the most active recent channel.

The three recent opportunities show geographic activity concentrated in Florida, Texas, and the Upper Midwest (Minnesota and Oregon as MMCAP participants). Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: deadline date appears inconsistent with posting date). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor input on direct-to-manufacturer prescription fulfillment models before issuing a formal RFP. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026, with proposals due March 26, 2026, to establish multi-award contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson. If pursuing this code, verify that the issuing body's actual commodity alignment matches your service or product line, as the formal code definition and documented buying activity show material divergence.